Structure via PubChem · Public domain (PubChem)
زولمیتریپتان
Sign in to saveAlso known as (S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one, 4-{[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl}oxazolidin-2-one, 4-{[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl}oxazolidin-2-one
Zolmitriptan, sold under the brand name Zomig among others, is a serotonergic medication which is used in the acute treatment of migraine attacks with or without aura and cluster headaches. It is taken by mouth as a swallowed or disintegrating tablet or as a nasal spray.
Chemical data
- Formula
- C16H21N3O2
- Molecular weight
- 287.36 g/mol
- IUPAC name
- (4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one
- SMILES
- CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3
- InChIKey
- ULSDMUVEXKOYBU-ZDUSSCGKSA-N
- XLogP
- 2.2
- Polar surface area
- 57.4 Ų
- H-bond donors
- 2
- H-bond acceptors
- 3
- Formal charge
- 0
via PubChem
Research
730 papers- Zolmitriptan.2006
- Zolmitriptan.2026
- Intranasal zolmitriptan.Expert opinion on pharmacotherapy · 2005
- Zolmitriptan (Zomig).Expert review of neurotherapeutics · 2004
- Zolmitriptan: a review of its use in migraine.Drugs · 1999
via PubMed